… BRAF V600E, through overactivating the … that BRAF V600E might play an important role in
LNM-related mortality risk in PTC, thus differentiating LNM in wild-type BRAF PTC and BRAF-…

… the BRAF gene has been identified as the most common genetic event in papillary thyroid
carcinoma (9… Here, we demonstrate that progression from papillary thyroid carcinoma to poorly …

… features of BRAF-positive papillary thyroid cancer (PTC) and association with age. … BRAF
mutation and more aggressive tumor behavior is limited to older patients, and therefore BRAF …

… In papillary thyroid carcinomas, this mutation is associated … BRAF as a potential therapeutic
target for thyroid carcinoma. … (c) papillary thyroid carcinoma with the V600E BRAF mutation …

… variant papillary thyroid cancers, which traditionally are not BRAF positive. I think that that
accounts for why we also have a higher percentage of BRAF … the utility of BRAF in the long run. …

… thyroid conditions. Morphologically, these malignancies have virtually always features of
differentiated papillary thyroid carcinoma (… BRAF(V600E) mutation has emerged as the most …

… It has been reported that prevalence (80 to 90 %) of BRAF V600E mutation in papillary
thyroid carcinoma in Korean patient was higher than that (approximately 45 %) of Western …

… High prevalence and possible de novo formation of BRAF mutation in metastasized
papillary thyroid cancer in lymph nodes. J Clin Endocrinol Metab 90, 5265–5269, doi:10.1210/jc.…

… V600E mutation is the most common genetic alteration in thyroid cancer. However, its …
of BRAF V600E and the clinicopathological features of classic papillary thyroid carcinoma (PTC). …

… selective inhibitor U0126, without altering BRAF's effects in wild-type … BRAF V600E -positive
thyroid cancer. In this study, we report that BRAF-activated BANCR may function as a tumor …